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ABSTRACT
This study investigated the role and mechanism of Hyperhomocysteinemia (HHcy) on vascular remodeling in mice. We assessed the effect of HHcy on vascular remodeling using a carotid arterial vein patch model in mice with the gene deletion of cystathionine-beta-synthase (Cbs). Vein grafts were harvested 4 weeks after surgery. Cross sections were analyzed using Verhoeff-van Gieson staining,
Masson's Trichrome staining, and immunostaining for morphological analysis and protein level assessment. The effect of Hcy on collagen secretion was examined in cultured rat aortic smooth muscle cells (RASMC). We found that Cbs -/-mice with severe HHcy exhibited thicker neointima and a higher percentage of luminal narrowing in vein grafts. In addition, severe HHcy increased elastin and collagen deposition in the neointima. Further, severe HHcy increases CD45 positive cells and proliferative cells in vein grafts. Finally, Hcy increases collagen secretion in RASMC. These results demonstrate that HHcy increases neointima formation, elastin and collagen deposition following a carotid arterial vein patch. The capacity of Hcy to promote vascular fibrosis and inflammation may contribute to the development of vascular remodeling.
INTRODUCTION
Hyperhomocysteinemia
(HHcy) is an independent risk factor for cardiovascular disease (1). It was reported that plasma total homocysteine (Hcy) levels are a strong predictor of mortality in patients with angiographically confirmed coronary artery disease (2) . Several mechanisms have been proposed to explain cardiovascular pathological changes associated with HHcy. These include endothelial dysfunction and damage (3, 4) , dysregulation of cholesterol and triglyceride (TG) biosynthesis (5,6), thrombosis activation (7, 8) , and stimulation of vascular smooth muscle cell (SMC) proliferation (9, 10) . Although these studies established that Hcy has profound atherogenic effects, the mechanisms by which HHcy contributes to arteriosclerosis remain largely unknown.
Mechanical injury is a major cause of atherosclerosis. The most frequently occurring post-injury atherosclerosis is restenosis of the coronary artery following angioplasty or bypass surgery. Despite increased surgical experience and technical breakthroughs, restenosis occurs in 30-50% of patients undergoing simple balloon angioplasty and in 10-30% of patients who receive an intravascular stent (11, 12) . Therefore, experimental studies are important for a better understanding of the mechanisms for restenosis. The pathophysiology of restenosis is complex and incompletely understood. Evidence strongly suggests that restenosis is a maladaptive response of the coronary artery to trauma induced during angioplasty consisting of thrombosis, inflammation, cellular proliferation, and extracellular matrix production that together contribute to postprocedural lumen loss (13, 14) . It was suggested that Hcy increases collagen expression in cultured vascular SMC and in atherosclerotic plaques in apolipoprotein E (apoE) knockout mice (15, 16) . We previously reported that HHcy impaired reendothelialization and promoted neointima formation using a carotid artery air-dry endothelial denudation model (17) . However, the role of Hcy on vascular remodeling following mechanical injury has not been studied. To assess the role of HHcy in intimal hyperplasia and vascular remodeling, post-injury remodeling was evaluated using a carotid arterial vein patch model. We studied vascular remodeling in response to mechanical injury in the mice with gene deletion of cystathionine-beta-synthase (Cbs). We used carotid sections for morphometric and immunohistochemical analysis to characterize cellular populations in the lesion, and to identify the expression of potential target molecules. Moreover, we observed the long-term effects of Hcy on collagen secretion in cultured rat aortic SMC (RASMC).
MATERIALS AND METHODS
CBS mice and Hcy measurement
A genetic HHcy model with the gene deletion of cystathionine beta-synthase (CBS), which catalyzes Hcy to cystathionine, was used in the present study. CBS mice were purchased from Jackson Laboratory (Bar Harbor, ME) and backcrossed 6 generations to achieve approximately 98% purity in a C57BL/B6 genetic background. We used polymerase chain reaction (PCR) to genotype the mice as described (17) , which were all fed a regular rodent diet after weaning. All animal care and procedures conform to NIH guidelines.
We collected mouse plasma at the end of each experiment and measured Hcy concentrations by liquid chromatography electrospray tandem mass spectrometry methods using 25 µL of mouse plasma diluted to 100 µL with reverse osmosis water as previously described 17 .
Carotid arterial vein graft model
We performed carotid artery vein graft surgeries on 2 groups of CBS mice at the age of 12 weeks: homozygous Cbs deficient (Cbs -/-) mice (n=5) and Cbs wild-type (Cbs +/+ ) mice (n=9). This model mimics human coronary artery bypass surgery, which is the most effective means of treatment for patients with multivessel coronary artery disease. The mouse vein graft surgery procedure was performed on anesthetized mice under a dissecting microscope as described (18) . In brief, the left external jugular vein from C57 mouse was dissected from the main trunk. A segment of the jugular vein (≈5 mm long) was sutured into place to repair a longitudinal defect (about the same length as the jugular vein patch) in the left (ipsilateral) carotid artery. The graft was harvested at 4 weeks after surgery.
Histology and morphology analysis
The grafts, together with a short segment of the native carotid artery, were harvested at 4 weeks after surgery by cutting at the centre of the graft. One portion was processed for paraffin embedding and the other for cryostat sectioning. Consecutive sections (5 µm) were cut from the centre of the graft to the proximal and distal ends at the junction with the native carotid artery. In total, about 45 sections were cut and divided over 15 slides, so that every slide contained three sections at 150-µm intervals (equivalent to 30 sections). Paraffin sections were treated with Verhoeff-van Gieson staining (showing elastin as black) and subjected to quantitative morphological analysis. The neointima (NI) was defined as the region between the internal elastic lamina (IEL) and the lumen, and the percentage luminal narrowing was calculated as 100x (difference between area inside the IEL and area of the lumen ÷ area inside the IEL). Masson's trichrome staining stained collagen content as blue. We determined elastin and collagen-positive area by using computerassisted color gated measurements (Image-Pro Plus) and expressed the data as a percentage. Cryostat sections were immunostained with alkaline phosphatase-conjugated antialpha-smooth muscle actin antibody (Sigma, USA), antitype 1 collagen antibody (Biodesign, USA), and antibodies against CD45, a common antigen of leukocytes and proliferating cell nuclear antigen (PCNA), a marker of proliferative cells (Oncogene Science, USA). The specificity of immunohistochemical staining was confirmed in relevant tissue sections by omitting primary antibodies.
Cell culture
The long-term effect of Hcy on SMC was determined by growing rat aortic smooth muscle cells (RASMC) for 3 weeks with or without Hcy in the culture medium. RASMC were cultured in DMEM medium (Gibco, USA) containing 10% CS (Bio-Whitaker, USA) at 37°C in 95% air and 5% CO 2 . RASMC cultures from passages 6 to 7 were used. Confluent cells were treated with 50 or 500 µM DL-Hcy (Sigma-Aldrich, USA), 0.2 mmol/L L-proline (Sigma-Aldrich, USA) and 50 mg/mL ascorbic acid (Sigma-Aldrich, USA) for an additional 3 weeks. Cell culture media were refreshed every three days.
Western blot analysis
Cell cultured medium, the supernatant, was collected for collagen secretion analysis using Western Blot. Protein was separated on 7% polyacrylamide gels and transferred it to polyvinylidene difluoride membranes, which were then incubated with rabbit anti-rat type 1 collagen 1 monoclonal antibody (1:500) (Biodesign, USA). Blot was stained with Ponceau S for loading control.
Statistic methods
Data was expressed as mean ± SEM. Statistical comparison of animal results was analyzed by the unpaired t test using the SPSS 17.0 software.
P<0.05 was considered statistically significant. 
RESULTS
HHcy accelerates post-injury neointima formation in Cbs
-/-mice In response to arterial blood pressure, the vein graft shows outward expansion. A robust neointima lines much of the venous portion of the arterial wall at 4 weeks after surgery ( Figure 1A and 1B) . This model is highly reproducible in neointimal formation. Most of the newly formed neointima stained positive for alpha-SMA, which is consistent with a smooth muscle cell phenotype ( Figure  1C ). We found that HHcy Cbs -/-mice (plasma Hcy 310 µm) had significant larger and thicker neointima and a higher percentage of luminal narrowing compared with that in Cbs +/+ mice ( Figure 2B ).
HHcy increases neointimal elastin deposition in Cbs
-/-mice Verheoff-van Gieson staining indicates the presence of elastin with a black stain. Normal artery has well-organized and circumferentially oriented elastin laminea ( Figure 1D ). However, the neointimal elastin is disordered and fragmented (Figure 2A ). Elastin protein is greatly increased and much disordered in the neointimal area of vein grafts in Cbs -/-mice compared with that in Cbs +/+ mice ( Figure 2A ). Elastin level, expressed as a percentage of area, accounted for 17.87±1.70% of the neointimal area in Cbs -/-mice in comparison with 7.74±2.95% of the neointimal area in Cbs +/+ mice (p<0.05, Fig 2B) .
HHcy increases collagen deposition in the lesion in
Cbs
-/-mice We analyzed total collagen levels in the vein graft by Masson's trichrome staining and found that collagen deposition is largely increased in in Cbs -/-mice ( Figure 3A) . The adventitial area of the vein graft adjacent to the elastic lamina stained strongly for collagen (Fig 3A) . Total collagen content, expressed as a percentage of the section area, is significantly increased in the adventitial area in Cbs -/-mice compared with that in Cbs +/+ mice (59.39±5.77% versus 41.72±4.77%, p<0.05), as well as in the whole vessel cross-section (50.92±4.27% versus 38.15±6.70%, p<0.05) ( Figure 3B ). Type 1 collagen Figure 2 . Severe HHcy promotes vascular remodeling and elastin production in the neointima in the vein graft in Cbs -/-mice. The mouse vein graft surgery procedure was performed on Cbs mice at the age of 12 weeks as described in Figure 1 and in the section of Methods. The vein patch grafts, together with a short segment of the native carotid artery, were harvested at 4 weeks after surgery and processed for paraffin embedding (VVG) and cryostat sections (alpha-actin). Mouse plasma was collected at the end of each experiment (at age 16 weeks). A. Photomicrographs of morphological analysis. Sections are oriented with a vein patch on top and artery on bottom. VVG staining shows elastin as black. Anti-alpha smooth muscle actin (alpha-SMA) antibody staining shows smooth muscle cell as red. B. Quantitative analysis. Neointimal area and thickness were analyzed by computerized planimetry using the updated Image-Pro Plus program. We determined the elastin positive area by computerassisted color gated measurement (Image-Pro Plus) and expressed the data as a percentage. The neointima was defined as the region between the internal elastic lamina (IEL) and the lumen. The percentage luminal narrowing was calculated as 100 x (the difference between area inside the IEL and area of the lumen ÷ the area inside the IEL. Hcy significantly increased neointima formation, luminal narrowing and neointima elastin deposition. C. (Fig  3C) . Figure 4B ).
HHcy increases CD45
HHcy increases the number of proliferating cells in the lesions in Cbs
-/-mice We found a high content of PCNA-positive cells, a marker of cellular proliferation, in the neointima and adventitia of the vein graft ( Figure 4A and B) . PCNA positive proliferating cells are significantly increased in the whole vessel cross-section in Cbs -/-mice compared to that in Cbs +/+ mice (69.56±8.54% versus 47.41±21.64%, p<0.05, Figure 5C ). -/-mice. The mouse vein graft surgery procedure was performed on Cbs mice at the age of 12 weeks as described in Figure 1 and in the section of Methods. The grafts, together with a short segment of the native carotid artery, were harvested at 4 weeks after surgery by cutting at the center of the graft. One portion was processed for paraffin embedding and the other for cryostat sectioning. A. Photomicrographs of collagen staining. Paraffin-embedded cross sections of the vein graft stained for total collagen by Masson's trichrome method and cryostat sections immunostained with antibody against type 1 collagen. Collagen shows as blue and type 1 collagen as brown. B&C. Total collagen and type 1 collagen quantification. Total collagen and type 1 collagen area were analyzed by computerized planimetry. Notice that total collagen deposition is increased in the adventitia, and type 1 collagen deposition is increased in the neointima in Cbs -/-mice. Values represent mean±SEM, n=9, p values from independent t test * p<0.05 versus Cbs +/+ group.
Hcy stimulates collagen 1 secretion in RASMC
We reproduced HHcy-induced type 1 collagen expression in cultured RASMC and found that DL-Hcy induced type collagen 1 secretion in a dose sensitive manner. DL-Hcy, at the concentration of 50µmol/L, increased the levels of secreted type 1 collagen 157% compared with the control group. 500 µmol/L DL-Hcy increased type 1 collagen 309% in cultured RASMC ( Figure 5 ).
DISCUSSION
Mechanical injury is a significant cause of atherosclerosis. The most frequently occurring post-injury pathology in the vessel wall is restenosis of the coronary artery following angioplasty or bypass surgery, which is a major cause of morbidity and mortality in cardiovascular patients (19, 20) . Vein grafts are the major conduits for bypass surgery in patients with coronary or peripheral arterial diseases. However, about 20% of vein grafts develop partial or total obstructions or restenosis within 5 years of the bypass surgery due to post-injury atherosclerosis or vascular remodeling (21) . In this study, in order to evaluate the effect of HHcy on intimal hyperplasia and vascular remodeling post vein graft bypass surgery, we used a carotid arterial vein graft model. The carotid arterial vein graft model is preferable because it mimics human coronary angioplasty procedures, does not involve immune rejection, and is highly clinically relevant. This surgical model is a valuable tool for investigating the effects and mechanisms of cardiovascular disease risk factors on post-injury atherosclerosis and vascular remodeling. We previously reported that high methionine diet-induced HHcy impairs reendothelialization and promotes neointima formation post-endothelial injury using a carotid artery air-dry endothelial denudation model (17) . The air-dry endothelial denudation model introduces consistent endothelial injury without medial wall damage and is the ideal model to examine endothelial phenotype and consequential vascular remodeling post endothelial injury. In the present study, we evaluated HHcy's on vascular remodeling in a vein graft model, which emphasizes VSMC phenotype and mimics angioplasty procedures.
The current study demonstrated that severe HHcy promoted post-injury neointima formation and led to luminal narrowing in bypass vein grafts. Atherosclerosis is characterized by extensive thickening of the arterial intima that is associated both with vascular smooth muscle cell (VSMC) proliferation and excessive deposition of the extracellular matrix (ECM) protein by intimal VSMC (22, 23) . Moderate HHcy is associated with an increased incidence of carotid artery stenosis in humans (2) . Our previous study demonstrated that Hcy promotes vascular SMC proliferation in cultured human and rat VSMC (9) . Here, we confirmed that most of the newly formed neointima stains positive for alpha-SMA, a typical smooth muscle cell phenotype. We also found that many of the neointimal cells are stained by the anti-PCNA antibody, indicating active proliferation of VSMC in the neointima. Therefore Hcy promotes vascular SMC proliferation, which may contribute to the vein graft neointima formation.
The ECM is composed of vastly different macromolecules such as collagen, elastin, glycoproteins and proteoglycans (24, 25) , which provides structural support and scaffolds to stabilize vasculature. Each component of the ECM possesses unique structural properties and participates in several key events such as cell migration, cell proliferation, lipoprotein retention, and thrombosis (26) . Excessive deposition of ECM protein in the vessel wall contributes to vessel wall thickness and stiffness, leading to hypertension and atherosclerosis. Several lines of evidence suggest that HHcy may alter vascular matrix structure (27, 28) . In the present study, we found that HHcy induced a fibrotic-intensive vascular remodeling because elastin increased by 131% in the neointima and induced total collagen increased by 142% in the adventitia and 133% in the whole cross section of the vein graft in Cbs -/-mice. We also found that the neointima area of the vein graft exhibits severe elastin disorder. The fragmented deposits of elastin and loosely arranged collagen bundles were usually more prominent in the mid to deep musculoelastic layer than in the subendothelial zone. This is consistent with McCully's first report that the accumulation of collagen in atherosclerotic plaques in children with premature atherosclerosis resulted from severe HHcy (29) . Previous studies also reported that HHcy increased collagen accumulation in the carotid artery of mice and rats (27, 30) . It is known that collagen is a major component of atherosclerotic plaques, which makes up about 60% of the total protein in the lesion (27, 31) . Collagen fibers can occupy about 80% of the section area in the samples of human coronary restenotic lesions (32) . Because type 1 collagen may account for 70% of all collagen in plaques (33), we examined type 1 collagen content by immunohistochemistry staining and found that type 1 collagen is increased by 136% in the neointima and by 72% in the whole cross section of the vein graft in Cbs -/-mice. We also examined the effect of Hcy on type 1 collagen production in cultured RASMC. We reproduced our in vivo finding and found that Hcy can induce collagen secretion in a dosesensitive manner, and that 500 µM Hcy increased type 1 collagen secretion by 189.56%. Hcy induced vascular fibrosis, as evidenced by increased collagen and elastin deposition may lead to decreased vessel wall elasticity and increased vascular remodeling. Uncontrolled collagen and elastin accumulation leads to arterial stenosis and vessel wall stiffness, which can result in an advanced pathophysiological progression of the cardiovascular disease.
Moreover, we found HHcy increased the recruitment of CD45 positive leukocytes in the adventitia, particularly in the venous portion of the composite vessel. Many of the adventitial cells are also PCNA positive, suggesting an active proliferation of leukocytes in the adventitia. These results suggest HHcy may augment an inflammatory response following vein graft injury and consequently contribute to the development of arteriosclerosis.
In summary, we reported here that severe HHcy increases neointima formation and vascular fibrosis in bypass vein grafts. We postulated that HHcy stimulates VSMC proliferation and collagen I production, inducing fibrosis and a decrease of elasticity, leading to arterial remodeling and vascular resistance. Our results support a cellular mechanism for vein graft-related atherogenesis in HHcy and provide insight into a potential preventive treatment.
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